The purpose of this study was to investigate whether PTX3 would be a useful biomarker compared to other biomarkers for detecting CTEPH especially with respect to differentiation from clinically stable status after acute episode of PTE. Here, PTX3 is linked to chronic thromboembolic pulmonary hypertension.